58 Biggest Movers From Yesterday

Gainers

• Eargo, Inc. EAR shares climbed 59.7% to close at $7.28 on Thurs
• after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
• Alterity Therapeutics Limited ATHE gained 33.8% to settle at $1.11 after the company announced it was granted a new US patent for "Compounds for and Methods of Treating Diseases."
• China Natural Resources, Inc. CHNR surged 27.8% to close at $0.86.
• Vocera Communications, Inc. VCRA climbed 26.6% to close at $79.17 after Stryker announced a definitive agreement to acquire the company.
• Nanobiotix S.A. NBTX rose 22.2% to close at $9.85. NANOBIOTIX said first patient was enrolled in NANORAY-312 global Phase III registrational study of NBTXR3 in head and neck cancer.
• Kaival Brands Innovations Group, Inc. KAVL gained 21.4% to close at $0.7633 after declining more than 11% on Wednesday.
• IMAC Holdings, Inc. IMAC surged 21.1% to settle at $1.38.
• AgeX Therapeutics, Inc. AGE rose 20.1% to close at $1.20.
• Phunware, Inc. PHUN jumped 19.9% to settle at $3.07.
• Digital World Acquisition Corp. DWAC rose 19.7% to settle at $60.27.
• Ensysce Biosciences, Inc. ENSC gained 18.2% to close at $4.75.
• Magenta Therapeutics, Inc. MGTA shares jumped 16.1% to close at $5.18. Goldman Sachs upgraded Magenta Therapeutics from Neutral to Buy and raised the price target from $7 to $8.
• Beyond Meat, Inc. BYND surged 14.7% to settle at $67.06. The company recently announced the debut of Beyond Fried Chicken with KFC nationwide.
• VIA optronics AG VIAO gained 14.6% to close at $8.87.
• Richardson Electronics, Ltd. RELL rose 13.6% to close at $14.36 after the company reported a year-over-year rise in Q2 results.
• East Stone Acquisition Corporation ESSC jumped 13.2% to settle at $14.77.
• Allbirds, Inc. BIRD gained 12.2% to close at $15.23 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and lowered its price target from $23 to $17.
• Consumer Portfolio Services, Inc. CPSS rose 12.1% to close at $11.97.
• Resources Connection, Inc. RGP jumped 8.4% to close at $19.72 after reporting better-than-expected Q2 results.
• Bed Bath & Beyond Inc. BBBY gained 8% to close at $14.43 after the company reported Q3 earnings results and issued guidance.
• Lamb Weston Holdings, Inc. LW gained 7.5% to settle at $67.82 after the company announced better-than-expected Q2 EPS and sales results.
• SomaLogic, Inc. SLGC rose 4.1% to close at $10.76 after the company announced an exclusive partnership with Illumina to develop sequencing-based proteomic solutions.

Check out these big penny stock gainers and losers

Losers

• Dogness (International) Corporation DOGZ shares fell 61.9% to close at $3.33.
• Aligos Therapeutics, Inc. ALGS shares dipped 56.7% to settle at $4.59 on Thursday after the company announced that it has halted further development of its STOPS drug candidate, ALG-010133.
• Berkeley Lights, Inc. BLI fell 39.3% to close at $9.88 after the company issued weak sales forecast for FY21. The company said it sees FY21 sales of $84 million to $84.5 million, versus analysts’ estimates of $90.9 million and also projects FY22 sales growth of 30% year over year. The company’s CEO Eric D. Hobbs will transition to president of Antibody Therapeutics Line.
• OneSmart International Education Group Limited ONE fell 31.3% to close at $0.2749.
• Avalo Therapeutics, Inc. AVTX fell 31.3% to close at $1.21 after the company reported Phase 1b results for AVTX-002 in moderate to severe Crohn's disease patients and presented additional program updates at the 2022 investor event.
• Sutro Biopharma, Inc. STRO tumbled 27.9% to settle at $10.51. Sutro Biopharma announced updated data from the Phase 1 study of STRO-002, an antibody-drug conjugate, for patients with advanced ovarian cancer, which showed that as of the Nov. 8 cut-off date, seven patients had achieved partial responses, five patients had unconfirmed partial responses and the overall response rate was 33% in all evaluable patients.
• Olink Holding AB OLK dropped 27.8% to close at $11.33.
• Curis, Inc. CRIS fell 27.6% to settle at $3.4950 after the company reported updated data with additional encouraging clinical activity in Phase 1/2 study of CA-4948 monotherapy in targeted patients with relapsed or refractory AML and MDS.
• CNS Pharmaceuticals, Inc. CNSP shares fell 27.6% to close at $0.76 after the company reported a $11.5 million private placement priced at-the-market under Nasdaq rules.
• Reliance Global Group, Inc RELI dipped 24.2% to settle at $6.75.
• Applied UV, Inc. AUVI fell 19.9% to close at $2.37 after declining around 12% on Wednesday.
• Humana Inc. HUM dipped 19.4% to settle at $367.53 after the company reaffirmed its FY21 EPS guidance below analyst estimates.
• Heliogen, Inc. HLGN fell 19.3% to close at $7.88.
• Immix Biopharma, Inc. IMMX dropped 18.7% to settle at $5.49. The company recently announced the FDA granted Rare Pediatric Disease designation for IMX-110 for the treatment of a life-threatening form of pediatric cancer in children, rhabdomyosarcoma.
• Embark Technology, Inc. EMBK declined 16.8% to settle at $6.81 after The Bear Cave issued a short report on the company.
• PMV Pharmaceuticals, Inc. PMVP fell 16.3% to close at $19.04.
• Advanced Human Imaging Limited AHI fell 16.2% to close at $4.03.
• Greenbrook TMS Inc. GBNH dropped 16.2% to settle at $3.20.
• Zhangmen Education Inc. ZME fell 15.9% to close at $2.38.
• NLS Pharmaceutics AG NLSP dipped 15.8% to settle at $1.28. The company recently announced the USPTO granted the company U.S. Patent No. 11207271, entitled A Mazindol Ir/Sr Multilayer Tablet And Its Use For The Treatment Of Attention Deficit/Hyperactivity Disorder.
• Jowell Global Ltd. JWEL fell 15.8% to close at $5.11.
• Longeveron Inc. LGVN declined 15.7% to settle at $10.00. Longeveron recently announced initiation of the Phase 2a clinical trial of lomecel-B for the treatment of Alzheimer's Disease.
• Stran & Company, Inc. STRN fell 15.4% to close at $4.95. Stran & Company announced a multi-year contract with a 'large national healthcare company.'
• Nuvalent, Inc. NUVL declined 15.4% to close at $14.77.
• uCloudlink Group Inc. UCL dipped 15.1% to settle at $2.41.
• Marpai, Inc. MRAI fell 14.4% to close at $3.64.
• Schnitzer Steel Industries, Inc. SCHN shares fell 13.9% to settle at $46.10 after the company reported worse-than-expected Q1 EPS and sales results.
• ATA Creativity Global AACG declined 13.9% to settle at $1.98 after dropping around 10% on Wednesday.
• Vivint Smart Home, Inc. VVNT declined 12.5% to close at $7.66. RBC Capital downgraded Vivint Smart Home from Outperform to Sector Perform and announced $11 price target.
• GoHealth, Inc. GOCO dropped 12.3% to settle at $2.86.
• MicroVision, Inc. MVIS shares fell 9.3% to close at $4.48 after dropping more than 12% on Wednesday.
• REE Automotive Ltd. REE dropped 9% to close at $5.84. REE Automotive named David Goldberg as Chief Financial Officer.
• Ebang International Holdings Inc. EBON shares fell 8.8% to close at $1.04 after gaining around 10% on Wednesday.
• Data Storage Corporation DTST shares fell 8.2% to settle at $3.79. Data Storage shares climbed more than 33% on Wednesday after the company announced a multi-million dollar contract with a professional sports team.
• Hoth Therapeutics, Inc. HOTH shares fell 7.8% to close at $1.07. Hoth Therapeutics recently announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ.
• Connect Biopharma Holdings Limited CNTB fell 7% to close at $4.65. Connect Biopharma recently reported detailed dataset from global Phase 2b trial of CBP-201 in adult patients with moderate-to-severe atopic dermatitis.